Head to Head Analysis: Oncolytics Biotech (ONCYF) vs. The Competition

Oncolytics Biotech is one of 524 public companies in the "Pharmaceutical preparations" industry, but how does it compare to its competitors? We will compare Oncolytics Biotech to related companies based on the strength of its analyst recommendations, risk, profitability, earnings, valuation, dividends and institutional ownership. As a group, "Pharmaceutical preparations" companies have a potential upside of 67.71%.

from Biotech News